The Monark trial: where now for boosted protease inhibitor monotherapy?
AIDS
.
2008 Mar 30;22(6):777-9.
doi: 10.1097/QAD.0b013e3282f3f17f.
Authors
Andrew Hill
,
Bernard Hirschel
,
Christine Katlama
PMID:
18356608
DOI:
10.1097/QAD.0b013e3282f3f17f
No abstract available
Publication types
Comment
Editorial
MeSH terms
Antiretroviral Therapy, Highly Active
Clinical Trials as Topic
HIV Infections / drug therapy*
HIV Protease Inhibitors / therapeutic use*
HIV*
Humans
Treatment Outcome
Substances
HIV Protease Inhibitors